PDM08 Clinical Trial in Advanced Solid Tumors

Summary

This phase I study in adult patients with advanced solid tumours is designed to evaluate toxicity, drug exposure (pharmacokinetics) and drug action (pharmacodynamics) of a new molecule, PDM08, administered twice a week cycles of 4 weeks. This drug has shown antitumoral activity in several murine cancer models.

Timeline

Start

2011-06

Primary completion

2012-06

Completion

2013-01

Drugs

Indications